medigraphic.com

2008, Number 1

<< Back Next >>

Rev Mex Anest 2008; 31 (1)

Anesthesia and anaphylaxis

Rivera-Ramírez ÓA, Mendoza-Magaña MJE, Racette M

Language: Spanish
References: 27
Page: 37-44
PDF size: 61.62 Kb.


ABSTRACT

The allergic reaction in anesthesia happens more frequently that one can imagine. The principal problem is that, in most cases, the patient is unaware of such antecedents. The purpose of this article is to give the definition of anaphylaxis, reveal the immunopathologic mechanisms involved in allergic reactions most faced by anesthesiologists and how to treat and manage a patient with suspected anaphylaxis reaction. The perfect understanding of the cellular physiopathology, of the consequences of the activation of the cellular membranes, mastocytes and basophiles, and of the pharmacology of the mediators like histamine, protease and lipid is of great importance. The knowledge and fast identification of the agents that most frequently cause an anaphylactic reaction, like muscle relaxants, latex, antibiotics, hypnotics, etc., is the key to prevention and treatment of anaphylactic reactions in programmed anesthesia and emergencies.


REFERENCES

  1. Portier MM, Richet C. De l’action anaphylactique decertains venims. C R Soc Biol 1902;54:170-2.

  2. Sampson HA, Muñoz-Furlong TJ, Galli SJ, Golden DB, Gruchalla RS, Harlor Jr, et al . CA symposium on the definition and management of anaphylaxis: Summary report. J Allergy Clin Immun 2005;115:584-91.

  3. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003;97:1381-95.

  4. Lieberman P. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allegy Clin Immunol 2005;115: 483-523.

  5. Coombs RRA, Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. Gell PGH, Coombs RRA, Lachmann PJ editors. Clinical aspects of immunology. 3a. Edición Oxford 1975:761-81.

  6. Immunol allergy. Clin North Am 2001;21:611-34.

  7. Jhonson RF. Anaphylactic Shock: pathophysiology, recognition and treatment. Semin Respir Crit Care Med 2004;25:695-703.

  8. Laxenaire MC, Mata-Bermejo E, Moneret-Vautrin DA, Gueant JL, Widmer S. Substances anesthésiques responsables de chocs anaphylactiques. Enquete multicentrique francaise. Ann Fr Anesth Réanim 1990;9:501-506.

  9. Laxenaire MC, Mata-Bermejo E, Moneret-Vautrin DA. Life threatening anaphylactoid reactions to propofol (Diprivan). Anesthesiology 1992;77:275-80.

  10. McKinnon RP, Wildsmith JAW. Histaminoid reactions in anaesthesia. Br J Anaesth 1995;74:217-228.

  11. Laxenaire MC, Monteret-Vautrin DA. Gueant JL. Allergie aux agents anesthésiques. Quoi de neuf? Congrès national d’anesthésie réanimation. Conférences d’actualisation. Masson. París. 1992:231-244.

  12. Kaliner M. Effects of infused histamine: analysis of the effects of H-1 and H-2 receptor antagonists on cardiovascular and pulmonary responses. J Allergy Clin Immunol 1981;68:365-71.

  13. Mitsuhata H. Role of NO in anaphylactic shock. J Clin Immunol 1995;15:277-83.

  14. Marone G, Stellato C, Mastronardi P, Mazarella B. Mechanisms of activation of human mast cells and basophils by general anaesthetic drugs. Ann Fr Anesth Reanim 1993;12:116-125.

  15. Stellato C, Casalato V, Ciccarelli A, Mastronardi P, Mazzarella B, Marone G. General anaesthetics induce only histamine release selectively from human mast cells. Br J Anaest 1991;67:751-758.

  16. Moneret-Vautrin DA, Moriste M. Epidemiology of life-threatening and letal anaphylaxis: a review. Allergy 2005;60:443-51.

  17. Mertes PM, Laxenaire MC, Alla F. Groupe d’etudes de rèactions anaphylactoïdes peranesthésiques. Anaphylactic and anaphylactoid reactions ocurring during anesthesia in France in 1999-2000. Anesthesiology 2003;99:536-45.

  18. Laxenaire MC, Moneret-Vautrin DA, Sigiel-Marcadella EH. Facteurs favorisant et aggravant les réactions anaphylactoides. In: Le risque allergique en anesthésie réanitation. Ed. Masson Paris 1990:38-45.

  19. Sampson HA. Fatal and near fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992:327:380-4.

  20. Simon GA. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005;5:359-64.

  21. Sampson H. Anaphylaxis and emergency treatment. Pediatrics 2003;111:1601-8.

  22. Liebermann P. The diagnosis and management of anaphylais. An updated practice parameter. J Allergy Clin Immunol 2005:115:483-523.

  23. Jonhson RF. Anaphylactic shock: pathophysiology, recognition, and treatment. Semin Respir Crit Care Med 2004;25:695-703.

  24. Toogood JH. Beta blocker therapy and the risk of anaphylaxis. CMAJ 1987;136:929-33.

  25. Pumphrey R. Anaphylaxis: Can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004;4:289-90.

  26. Leynadier F, Sansarricq M, Didier JM, Dry J. Dépistage des allergiques aux myorelaxants par prick-tests préchargés. Presse Méd 1986;15:2072.

  27. Leynadier F, Sansarricq M. Reproductibilité des tests cutanés intradermiques après anaphylaxie aux myorelaxants. Presse Méd 1987;16:523-525.




2020     |     www.medigraphic.com